EyePoint Pharmaceuticals, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
5.05
-0.37 (-6.83%)
At close: Apr 1, 2025, 4:00 PM
5.28
+0.23 (4.53%)
After-hours: Apr 1, 2025, 4:26 PM EDT
EyePoint Pharmaceuticals Employees
EyePoint Pharmaceuticals had 165 employees as of December 31, 2024. The number of employees increased by 44 or 36.36% compared to the previous year.
Employees
165
Change (1Y)
44
Growth (1Y)
36.36%
Revenue / Employee
$262,261
Profits / Employee
-$793,152
Market Cap
347.08M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
EYPT News
- 5 days ago - EyePoint to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference - GlobeNewsWire
- 15 days ago - EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 27 days ago - EyePoint Pharmaceuticals, Inc. (EYPT) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 27 days ago - EyePoint Reports Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Corporate Developments - GlobeNewsWire
- 4 weeks ago - EyePoint Announces Participation at Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - EyePoint to Report Fourth Quarter and Full-Year 2024 Financial Results on March 5, 2025 - GlobeNewsWire
- 5 weeks ago - EyePoint to Present Corporate Update at TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 2 months ago - EyePoint: A Risky 'Buy' Ahead Of Key Readout For Long-Acting Eylea Rival - Seeking Alpha